Additional Locations, Texas Clinical Trials

test12 (test12)

test12

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

A Phase I study to evaluate the safety of a novel, orally available, selective, and potent small molecule inhibitor of the histone lysine methyl transferase MMSET (also known as NSD2/WHSC1) to prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multiple myeloma (RRMM).

University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center

 (9.2 away) Contact site

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy (VERDANT)

This study is open to people 50 years or older with an eye condition called geographic atrophy. The purpose of this study is to compare a medicine called BI 771716 with a medicine called pegcetacoplan. BI 771716 is being developed to treat people with geographic atrophy. Pegcetacoplan is a medicine …

Retina Foundation of the Southwest

 (7.1 away) Contact site

Trial 11

Baylor Scott & White AT&T Memory Center

 (7.1 away) Contact site

Cookie Testing  

Cookie Testing

Site

(online study)

RJ_StudyVirtualF  

Acne

Site1_RJ_StudyVirtual1N

(online study)

T2

we

8260013

(online study) Contact site

A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707)  

Primary Objectives:Evaluate the safety and tolerability of THOR-707 as a single agent and as a combination therapy (identify Dose Limiting Toxcitiy (DLTs) in Cohorts A, B, C, D, and G, and adverse events (AEs)/serious adverse event (SAE) profile in Cohorts A, B, C, D, E, F, and G)Define the Maximium …

Formal Site

(online study)

Shweta test study - do not use (PCOS 101)

ssdllksdlks

Natalia study 2 (-)  

-